GPhC-Regulated Supply: Wegovy vs Mounjaro Comparison
What Is The Difference Between Wegovy And Mounjaro From A GPhC Pharmacy?
The fundamental difference between Wegovy and Mounjaro lies in their mechanisms of action, both available through our GPhC-registered pharmacy (#9012878) with full regulatory oversight. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a single natural hormone involved in appetite regulation and blood sugar control. Mounjaro contains tirzepatide, which represents a newer approach as a dual agonist targeting both GIP and GLP-1 receptors simultaneously.
As a licensed UK pharmacy based in Leicester, EverydayMeds ensures both treatments are supplied through MHRA-regulated channels with complete traceability from manufacturer to patient. Our clinical team, working under GPhC oversight, reviews each consultation to determine which treatment may be most appropriate based on individual medical history, current medications, and weight management goals. This regulatory framework provides patients with confidence that they're receiving authentic prescription-only medicines through legitimate healthcare channels.
Wegovy vs Mounjaro Pricing: What's The Difference In Cost?
The pricing difference between Wegovy and Mounjaro reflects their distinct dosing schedules and market positioning, with both available through our transparent pricing structure. Wegovy follows a five-stage dose escalation protocol starting at £79.99 for the 0.25mg starter dose (after applying discount code FIRST40), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenient supply continuity, such as the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99.
Mounjaro typically requires fewer dose adjustments but follows a different cost structure entirely, making direct price comparisons complex without considering the full treatment journey. Both treatments qualify for our new customer discount code FIRST40 and returning customer code DOSE25, applied automatically at checkout. Our clinical assessment takes just 3 minutes, with prescriber review completed within 3 working days (or 24 hours with express service), followed by next-day temperature-controlled delivery once approved.
Clinical Evidence: What's The Difference Between Wegovy And Mounjaro Studies?
The clinical evidence base demonstrates distinct trial designs making direct comparisons inappropriate, though both treatments have shown significant efficacy in their respective programmes. Wegovy's evidence stems from the comprehensive STEP trial programme, with STEP 1 showing patients achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions, compared to 2.4% with placebo. The recent SELECT trial also demonstrated a 20% reduction in major cardiovascular events (HR 0.80) among patients taking Wegovy.
Mounjaro's SURMOUNT trials evaluated tirzepatide's dual-mechanism approach, though comparing percentage outcomes directly would be misleading due to different study populations, endpoints, and methodological approaches. Both treatments require combination with a reduced-calorie diet and increased physical activity, as mandated by their MHRA licences. Our clinical team helps patients understand these evidence profiles during consultation, ensuring realistic expectations aligned with published data from peer-reviewed research.
How Wegovy Works: Understanding The GLP-1 Difference
Wegovy's mechanism centres on semaglutide's action as a GLP-1 receptor agonist, mimicking the natural incretin hormone that signals fullness and regulates blood glucose levels. This single-target approach works primarily by slowing gastric emptying, reducing appetite through hypothalamic pathways, and promoting satiety after smaller meals. The once-weekly injection provides sustained hormone activity throughout the seven-day dosing interval, maintaining consistent appetite suppression. Unlike Mounjaro's dual-receptor approach, Wegovy focuses exclusively on the GLP-1 pathway, which has been extensively studied since the first GLP-1 agonists entered clinical practice. This established mechanism offers predictable effects on weight management when combined with appropriate lifestyle modifications. The FlexTouch pen delivery system ensures accurate dosing while simplifying the injection process for patients new to self-administered treatments.
Ordering Process: What's Different About Our GPhC-Regulated Service?
Our ordering process maintains full regulatory compliance while streamlining access to both Wegovy and Mounjaro through proper clinical channels. The 3-minute online assessment captures essential medical history, current medications, previous weight management attempts, and contraindications that our licensed prescribers review before making treatment recommendations. Following assessment submission, our clinical team (operating under GPhC registration #9012878) reviews each case within standard timeframes, with express 24-hour review available for urgent requests. Upon approval, medications are dispatched via next-day delivery using temperature-controlled packaging that maintains the 2-8°C storage requirements throughout transit. Our Leicester-based facility ensures UK-sourced medications reach patients with full cold-chain integrity, supported by tracking systems that confirm delivery and storage compliance. This regulated pathway ensures patients receive authentic prescription-only medicines through legitimate healthcare provision rather than unregulated online sources.
Storage Requirements: Key Differences Between Wegovy And Mounjaro
Storage requirements reveal practical differences that may influence treatment choice between Wegovy and Mounjaro for patients with specific lifestyle needs. Wegovy offers superior storage flexibility, remaining stable for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both treatments require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature stability provides advantages for frequent travellers or those with unreliable refrigeration access. The FlexTouch pen system used for Wegovy delivers precise dosing while protecting the medication from light exposure and temperature fluctuations. After each injection, both treatments should be stored with pen caps replaced and needles removed to prevent contamination. Our clinical team provides detailed storage guidance with each prescription, ensuring patients maintain medication efficacy throughout their treatment journey while understanding the practical implications of their chosen therapy.
GPhC Regulation: What Makes Our Wegovy vs Mounjaro Service Different?
Our GPhC registration (#9012878) provides verifiable legitimacy that patients can independently confirm through the pharmacyregulation.org database, distinguishing our service from unregulated online providers. This registration subjects EverydayMeds to regular inspections, audit requirements, and professional standards that ensure both Wegovy and Mounjaro are supplied through proper pharmaceutical channels. Our Leicester-based pharmacy operates under the same regulatory framework as high-street pharmacies, with additional safeguards for remote prescribing and medication supply.
The clinical governance framework requires our prescribers to maintain GMC registration, complete continuing professional development, and follow NICE guidelines when recommending either Wegovy or Mounjaro. This regulatory oversight ensures treatment recommendations consider individual patient factors, contraindications, and ongoing monitoring requirements. Patients benefit from the same legal protections and professional standards expected from traditional pharmacy services, with the added convenience of digital consultation and home delivery through our regulated platform.
Making Your Choice: Wegovy vs Mounjaro Through EverydayMeds
Both Wegovy and Mounjaro are available from EverydayMeds with full clinical support, allowing your prescriber to determine which treatment aligns best with your individual circumstances and medical history. The decision between these prescription-only medicines depends on factors including previous treatment responses, injection preferences, storage requirements, and cost considerations within your personal budget. Our clinical assessment captures these variables while screening for contraindications and drug interactions that might influence treatment selection. New customers can apply discount code FIRST40 at checkout, while returning patients benefit from code DOSE25, making both treatments accessible through our transparent pricing structure. Complete your 3-minute assessment today at https://everydaymeds.co.uk/collections/wegovy to begin your clinically-supervised weight management journey with confidence in our GPhC-regulated service. Our expert team stands ready to support your treatment decision with professional guidance based on current clinical evidence and regulatory best practice.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
